Introduction
Tumor cells are characterized by a variety of biological functions including deregulated proliferation, suppression of apoptosis, evasion of host immune response, neovascularization and metastatic spread to distant sites (Hanahan and Weinberg, 2000) . Of these, metastasis, the systemic dissemination and subsequent growth of tumor cells, is the most directly life threatening stage of the disease. Metastasis is critically dependent upon the ability of cells to move away from the primary tumor to gain access to the vascular or lymphatic systems which disperses cells to distant sites, where they escape the vasculature or lymphatics and can grow in a permissive microenvironment at a secondary location (Liotta et al., 1991) . All of these processes are critically dependent upon the ability of tumor cells to breach the basement membrane and to migrate through three-dimensional space within host tissues (Yamaguchi et al., 2005) . Tumor cell invasion is traditionally thought of as a late event in neoplastic progression, resulting from an iterative series of individual selective events (Fidler, 2002) . However, it is increasingly being recognized that tumor cell dissemination may also be a very early event during malignant progression, occurring before the detection of the tumor, that seeds the body with cryptic micrometastatic deposits (Bernards and Weinberg, 2002; van 't Veer et al., 2002) . This results in an insidious population of dormant invasive or metastatic cells awaiting subsequent activation, acting, in a sense, as tumour-specific stem cells (Weissman, 2005) . Given the critical importance of tumor cell invasion in cancer pathobiology, it is paramount that we understand the molecular mechanisms that regulate this complex phenotype.
Cellular invasion is an important, tightly regulated component of normal biological processes such as development, immune response and wound healing. In these circumstances invasion is stimulated in target cells by a variety of extracellular signals including extracellular matrix (ECM), soluble growth factors and chemokines. In the wound healing response, for example, agents like epidermal growth factor (EGF) and platelet-derived growth factor (PDGF) are generated to attract responsive cells, such as fibroblasts, that migrate towards the growth factor source. This invasive response is dependent upon activation of signaling pathways that result in both short-term and long-term cellular responses. These immediate responses include rapid and dramatic changes in cell adhesion, actin cytoskeleton, cell polarity and membrane organization, often regulated by the Rac-Rho pathway (Ridley and Hall, 1992) . Long-term responses include the activation of transcription factors that regulate prolonged changes in gene expression (Blatti et al., 1988; Lanahan et al., 1992) . Under normal circumstances, when the initiating signal is withdrawn, or the migrating cell reaches its destination, the invasive response attenuates and migratory fibroblasts can differentiate into stationary myofibroblasts that perform discrete wound healing functions (Grinnell, 1994) . The signal transduction cascades that are transiently activated by EGF and PDGF in responding cells during wound healing are composed of dominant oncogenic molecules, PDGFR, EGFR, Src, Ras, Raf, mitogen-activated protein (MAP) kinases, Jun kinase (JNK) kinases and PI3 kinase among others. Overexpressed growth factors and constitutively activated oncogenes are able to directly induce cell motility and invasion, in addition to their more well known mitogenic properties (Partin et al., 1988; Stolz and Michalopoulos, 1994) . EGF is a chemoattractant for tumor cells (Bailly et al., 1998) and paracrine stimulation of tumor cells by EGF is required for tumor cell motility in vivo (Wyckoff et al., 2004) . These growth factors are dependent upon the function of members of the Ras superfamily of small guanine 5 0 -triphosphate binding proteins. Activated Ras, Rac, Rho and Cdc42 in particular have long been recognized as regulators of tumor cell invasion (Hernandez-Alcoceba et al., 2000; Campbell and Der, 2004) . Ras expressing NIH 3T3 cells are capable of inducing experimental metastasis in nude mice (Bradley et al., 1986) . Similarly, invasion is enhanced in NIH 3T3 fibroblasts transformed by the oncogenes v-sis (PDGFR), v-erb-B (EGFR), v-mos, v-ras and v-fos (Melchiori et al., 1990) . In the vast majority of tumor cells, the signal tranduction pathways controlled by these molecules are constitutively active (Hanahan and Weinberg, 2000) . Oncogene activation is often an early step in neoplastic progression, suggesting that invasiveness may likewise be acquired early in tumor development (Fearon and Vogelstein, 1990; Scott et al., 2004) . A larger implication is that, like proliferation, tumor cell invasion may be seen as the deregulation of a normal biological function that results in the permanent elaboration of what is normally a transient, tightly regulated behavior.
The AP-1 complex Activation of the AP-1 transcription factor complex is a universal response of a wide variety of mammalian cells to a broad range of external stimuli, including growth factors, chemokines and ECM (Muller et al., 1984; Verma and Sassone-Corsi, 1987) . AP-1 is a dimeric transcription factor that consists of members of the Fos and Jun gene families, including FOS, FOSB, FOSL1 (Fra-1), FOSL2 (Fra-2), JUN, JUNB and JUND (Curran and Franza, 1988 ) that bind to variations of the consensus DNA binding site TGAg/cTCA, usually located in the promoter region of target genes (Figure 1 ). Transcription from both the FOS and JUN promoters is rapidly and transiently induced in cells that are treated with serum or peptide growth factors via oncogenemediated signal transduction networks (Eferl and Wagner, 2003) . Growth factor-induced signal transduction cascades also regulate the activity of pre-existing AP-1 dimers. Both Fos and Jun are phosphorylated and activated by the MAPK, RSK and JNK kinase systems (Pulverer et al., 1991; Smeal et al., 1991; Chen et al., 1993 Chen et al., , 1996 . This ubiquitous response to extracellular signals highlights a role for AP-1 in converting transient biochemical signals into permanent changes in gene expression that effect a cellular response to external stimuli.
In addition to being activated by oncogenic signal transduction cascades, AP-1 is itself strongly oncogenic. V-Fos was isolated from retroviruses that cause osteosarcomas in mice (Curran and Teich, 1982) and are able to transform murine fibroblasts and keratinocytes in vitro Lee et al., 1993) . V-jun was originally isolated from a retrovirus that causes sarcomas in chickens, and transforms chick embryo fibroblasts (Bos et al., 1988) . V-Fos transformed 208F rat fibroblasts express an elongated bipolar morphology and are capable of anchorage-independent growth, but are still dependent upon mitogens for proliferation, suggesting a separation of the morphological from the proliferative aspects of transformation in this system (Hawker et al., 1993; Miao and Curran, 1994) . Endogenous c-fos and c-jun are also oncogenes as indicated by their ability to morphologically transform murine fibroblasts, causing density and anchorageindependent growth in these cells (Miller et al., 1984; Bos et al., 1990) . Transgenic mice expressing c-Fos produce osteosarcomas, whereas v-Jun expressing mice develop tumors secondary to epidermal wounds (Schuh et al., 1990; Wang et al., 1995) . Oncogenic potential has also been demonstrated for other Fos proteins including FosB and Fra-1 (Kovary et al., 1991; Kustikova et al., 1998) . Interestingly, conditional expression of c-Fos in 208F rat fibroblasts from an IPTG inducible promoter requires an extended period of time, 3 days, to induce transformation, suggesting that secondary rate limiting events control morphological transformation in response to Fos expression (Miao and Curran, 1994) . Fos transformation requires expression of a DNA 5-methylcytosine transferase, DNMT1, that mediates epigenetic transcriptional repression, a rate limiting step for transformation in this system (Bakin and Curran, 1999) .
One consequence of the induction of both c-Fos and c-Jun in response to upstream oncogenic signal Figure 1 Prototypical AP-1 proteins. Top: C-Jun is a 39 kDa nuclear phosphoprotein that consists of an N-terminal transactivating domain (TA), a C-terminal region, the bZIP domain, that has a basic, DNA binding domain (DBD) followed by an a-helical 'leucine zipper' dimerization domain (LZ). Bottom: C-Fos is a 65 kDa nuclear phosphoprotein consisting of several N-and C-terminal transactivating (TA) and transrepressing domains (TR) and a central bZIP region. AP-1 consists of either homodimers of Jun family members or heterodimers between members of the Fos and Jun families. Dimerization is mediated by interaction of the leucine zippers to form a parallel coiled-coil that juxtaposes the two DNA binding domains that interact with the TGAg/cTCA, consensus sequence. Phosphorylation sites for the Jun kinase (JNK), extracellular signal regulated kinase (ERK), casein kinase II (CkII) and ribosomal S6 kinase (Rsk2) are indicated.
AP-1: a critical transcriptional regulator of invasion BW Ozanne et al transduction cascades is that AP-1 activity is high in a large number of tumors and transformed cell lines Eferl and Wagner, 2003) . Experiments that inhibit AP-1 activity in these model systems suggest a critical role for AP-1 in oncogenic transformation. Antisense c-fos is able to revert transformation by upstream oncogenes such as c-H-ras and v-sis (Mercola et al., 1987; Ledwith et al., 1990) . Dominant-negative constructs of c-fos and c-jun revert the transformed phenotype induced by activated Ras (Lloyd et al., 1991; Okuno et al., 1991) and inhibit the invasiveness and tumorigenesis of keratinocytes (Dong et al., 1997) . Experiments with cells derived from c-jun null mice have demonstrated that it is necessary for transformation and tumorigenesis by oncogenic ras (Johnson et al., 1996) . Together these experiments highlight two critical truths about AP-1. First, that deregulated AP-1 activity alone is sufficient for neoplastic transformation. Second, and more importantly, AP-1 activity is vitally necessary for the function of upstream dominant oncogenes, particularly members of the Ras-MAP kinase system. The crucial role that AP-1 plays in transformation, along with the close correlation between transformation and invasiveness, suggests that the AP-1 complex is also deeply implicated in regulating the invasive response. Retroviruses carrying v-fos FBR cause osteosarcomas in mice that are characterized as locally invasive (Price et al., 1972) . Expression of v-Fos in Src transformed cells enhances their mobility in vitro (Taniguchi et al., 1989) . Chicken embryo fibroblasts transformed by v-Jun also have enhanced motility and invasion (Bos et al., 1999) as are human MCF-7 breast carcinoma cells overexpressing c-Jun (Rinehart-Kim et al., 2000) . Conditional expression of an ER-Fos fusion protein induces mesenchymal to epithelial transition and invasion in murine breast epithelial cells (Reichmann et al., 1992) , a property that is shared by c-Jun and Fra-1 (Fialka et al., 1996; Kustikova et al., 1998) . Overexpression of AP-1 family members correlates with the development of invasive spindle-cell carcinomas in mouse skin tumorigenesis models (Zoumpourlis et al., 2000) and mice that are nullizygous for c-fos fail to form invasive carcinomas in this system (Saez et al., 1995) . The ability of AP-1 to mediate invasion in a variety of cell contexts, the critical role that AP-1 performs in oncogene biological activity and the importance of cell invasion in cancer metastasis, highlights the critical role AP-1 plays in cancer progression.
AP-1 target genes
The biological function of an oncogenic transcription factor such as AP-1 is mediated by the direct regulation of gene expression. In fact, the invasion-associated matrix metalloprotease MMP1 was among the first verified AP-1 target genes and several other MMPs, including MMP3 and MMP9, have long been known to be regulated by AP-1 in a variety of cellular contexts (Angel et al., 1987; Lee et al., 1987; Benbow and Brinckerhoff, 1997) . Identification of genes that are differentially expressed in quiescent v-fos transformed fibroblasts further supports a role for AP-1 in regulating invasion in vitro. Isolation of v-Fos target genes by differential screening identified a cohort of known mRNAs that have been shown to function in tumor cell invasion and metastasis (Hennigan et al., 1994) , including the protease Cathepsin L (Denhardt et al., 1987) , an S-100 calcium binding protein induced in metastatic cells, Mts-1 (Ebralidze et al., 1989) and the metastasis-associated gal-lectin Mac-2/L-34 (Raz et al., 1989) . Fos transformants also differentially express genes that directly regulate the cytoskeleton, including the actin binding protein ezrin and members of the tropomyosin family (Joos and Muller, 1995) . Putative Jun targets are also implicated in the invasive phenotype, including the matrix metalloproteinases MMP1, MMP3 and MMP9 (Bos et al., 1999) , the ECM associated protein osteonectin/SPARC (Briggs et al., 2002) the protein kinase C substrate SSeCKS (Cohen et al., 2001 ) and the motility and angiogenic factor, autotaxin (Black et al., 2004) . Consistent with these observations, v-fos transformed cells are constitutively invasive in a three-dimensional in vitro invasion assay, indicating that AP-1 activity, in the form of v-Fos expression, is sufficient for invasion in this system (Hennigan et al., 1994) . In contrast, untransformed parental fibroblasts are conditionally invasive in response to EGF. Fibroblast invasion in response to EGF is inhibited by antisense to c-jun and c-fos indicating that AP-1 activity is necessary for invasion in this system (Lamb et al., 1997a) .
Invasion effector genes
The elaboration of an invasive phenotype requires the expression of a large set of genes with diverse functions in order to coordinate the distinct activities that are necessary for tumor cell motility (Table 1) . In v-fos transformed fibroblasts, subsets of these differentially expressed genes function to coordinate specific aspects of invasion such as proteolysis, adhesion, and pseudopod formation. The differential expression of each gene in the program is necessary for efficient invasion. Thus, inhibition of a single upregulated gene or expression of a single downregulated gene could be sufficient to inhibit invasion. Together, the sum of these changes in gene expression constitute an AP-1 regulated multigenic program that mediates tumor cell invasion. For example, v-Fos transformants migrate in two-and three-dimensional cultures by extending a long pseudopod that has an area of dynamic membrane ruffles at its tip . Both up-and downregulated genes functionally interact to form pseudopods and support this mesenchymal mode of invasion. The v-Fos regulated gene, CD44, is a cell surface hyaluronan receptor that links to the actin cytoskeleton and contributes to a cell's ability to respond to chemotactic gradients. It is concentrated at the tips of elongating pseudopods in invasive v-Fos transformants (Lamb et al., 1997a) . Inhibition of CD44 expression by antisense oligonucleotides prevents invasion, clearly demonstrating that the upregulation of a single gene is necessary for Fos-induced invasion (Lamb et al., 1997a) . Another v-Fos induced gene, ezrin, a member of the ERM family of proteins, functions to link CD44 to the actin cytoskeleton (Joos and Muller, 1995) . In addition to upregulation, ezrin displays a change in intracellular distribution and degree of phosphorylation in v-Fos transformed cells. There is a ninefold increase in phosphorylated ezrin and the majority of it is associated with membrane sites of dynamic actin rearrangements. Localized ablation of ezrin in v-Fos transformants by chromophore assisted laser inactivation causes dramatic retraction of the pseudopods in these cells (Lamb et al., 1997b) . Another gene that is highly expressed by v-Fos transformants is the kelch-related protein, Krp1 . Krp1 is a member of the Kelch family of proteins that binds to actin and to nebulin repeat containing proteins. Like ezrin, Krp1 is located at the tips of extending pseudopods, where it colocalizes with F-actin in membrane ruffles. Increased expression of Krp1 enhances the length of pseudopod extensions in both Fos and Ras transformed fibroblasts Spence et al., 2000) . Downregulation of Krp1 expression by siRNA results in truncated pseudopods (Figure 2) (Spence et al., , 2006 and inhibits invasion of (Unpublished data). Krp1 interacts with a nondifferentially expressed protein, the actin binding protein, Lasp-1. Krp1 and Lasp-1 colocalize in the actin-rich tips of extending pseudopods and suppression of Lasp-1 by siRNA or dominant-negative mutants also truncates the pseudopod and inhibits invasion of these cells This demonstrates that the AP-1 regulated genes Krp1, CD44 and ezrin function cooperatively to mediate pseudopod extension. These genes may each be considered direct effectors of the invasive phenotype.
Signal transduction molecules AP-1 also regulates the expression of other genes that, although not direct effectors of invasion or migration, have significant impact on the invasive phenotype. Expression of v-Fos in immortalized human fibroblasts causes reduced levels of F-actin stress fibers and renders them highly invasive (Scott et al., 2004) . However, in marked contrast to rodent fibroblasts, v-fos does not induce a dramatic, bipolar, spindle-like morphology in human fibroblasts. Microarray analysis demonstrates the upregulation of 300 genes and the downregulation of 400 genes with significant overlap with the rat system (Scott et al., 2004) . Among these, the gene for the EGFR is induced approximately tenfold. Pharmacological inhibition of EGFR tyrosine kinase activity or inhibition of EGFR expression by siRNA renders the cells noninvasive, without affecting cell proliferation. Other positive signal transduction molecules, such as protein kinase C subunits, are also induced in these cells (Scott et al., 2004) . This suggests that AP-1 participates in a positive feedback loop, inducing the EGF receptor in response to EGF, rendering cells more sensitive to the invasive and chemotactic properties of EGF, thereby reinforcing the action of signal-transduction cascades and contributing to enhanced invasion in human tumor cells with activated oncogenes.
Invasion suppressor genes
In addition to the induction of genes that function as direct effectors of the invasive phenotype, v-fos represses genes that inhibit invasion. The follistatin related protein TSC-36 is significantly downregulated in v-fos transformants. TSC-36, a transforming growth factor (TGF)-b-induced transcript, is an extracellular (Liu et al., 2006) . Re-expression of TSC-36 inhibits invasion by v-fos transformed fibroblasts in vitro . Similarly, repression of a set of genes, the ECM molecule fibronectin, the cell adhesion molecule PCDHGC3 and the transcription factors STAT6 and RYBP have each been shown necessary for invasion in v-fos transformants ( Figure 2 ) McGarry et al., 2004) . Invasion suppressor genes, like TSC-36, may well serve as the basis of future therapies that specifically inhibit invasion in metastatic tumor cells.
Chromatin remodeling genes
Transformation of fibroblasts by v-fos is dependent upon the upregulation of both histone deacetylase (HDAC3) and the DNA methyltransferase, DNMT1 (Bakin and Curran, 1999; Ordway et al., 2004) . Treatment of cells with HDAC inhibitors such as trichostatin A and valproic acid dramatically inhibits invasion of v-fos transformants, reverts the transformed morphology and results in the re-expression of a subset of the downregulated genes, including PCDHGC3, STAT6 and RYBP (McGarry et al., 2004) . Similarly, microarray studies have identified a set of downregulated genes in v-fos transformed cells that are repressed, either totally or partially, via DNMT1 DNA methyltransferase activity. These include functional tumor suppressors such as SSeCKs and Lot 1, the cell adhesion molecule N-cadherin, and the TGF-b family member BMP4 (Ordway et al., 2004) . The indirect inhibition of these genes by v-fos via chromatin remodeling factors such as HDAC or DNMT1 activity suggests the existence of a cascade of gene expression controlled by complex epigenetic regulatory pathways downstream of AP-1 activity (Ordway and Curran, 2002; McGarry et al., 2004) .
A multigenic invasion program
The four general classes of Fos targets genes that are relevant to invasion that have emerged from studies on the v-fos transformed rat and human fibroblast systems are direct effectors of the invasive phenotype, dominant inhibitors of invasion, signal transduction molecules and chromatin remodeling factors. AP-1 regulates the expression of genes from all the classes that interact functionally to achieve tumor cell invasion. For example, pseudopod extension in v-fos transformed cells is dependent upon the increased expression of Krp1 and its interaction with the nondifferentially expressed protein Lasp-1. In turn, their interaction is dependent upon the HDAC-mediated downregulation of fibronectin, that decreases integrin-mediated Rho-ROCK activity. Suppression of Rho-ROCK activity is necessary for the Krp1-Lasp-1 interaction and localization in v-Fos-transformed cells because activation of either Rho or ROCK disrupts Krp1 and Lasp-1 interaction and inhibits pseudopod extension and invasion (Spence et al., , 2006 . This pathway is a good example of the complex interactions among AP-1 regulated genes that are necessary for pseudopod function and thus invasive activity. The ultimate clinical utility of these AP-1 target pathways presumes that the ability of AP-1 to regulate a program of gene expression that induces invasion in both human and murine fibroblasts also functions in clinically derived human tumor cells.
AP-1 invasion in human tumor cells
Many human tumor cells carry activated oncogenes that function in the growth factor oncogene signal transduction pathway that require AP-1 activity for transformation and, as a consequence, AP-1 activity is high in a large variety of human tumor cells (Wisdom, 1999; Ozanne et al., 2000; Milde-Langosch, 2005) . This, along with the AP-1-mediated invasion program seen in fibroblast model systems, suggests that 
Squamous cell carcinoma
The human squamous cell carcinoma-derived cell line A431 has greatly amplified EGFR (Merlino et al., 1984) . Expression of the dominant-negative mutant of c-jun, TAM67, inhibits A431 invasion without blocking cell proliferation (Malliri et al., 1998) . In this system, the cells become resistant to EGF-induced actin cytoskeleton, CD44 and ezrin rearrangements. Gene expression profiling identified protein kinase C theta (PKCy) as a gene that is upregulated in the presence of TAM67, suggesting that it is suppressed by AP-1 in these cells (Stapleton et al., 2002) . Expression of PKCy in A431 cells partially mimics the TAM67 phenotype. Inhibition of cell adhesion in A431 cells by a dominant-negative E-cadherin induces motility that is also inhibited by TAM67, indicating that AP-1 mediates motility in response to both cadherin and receptor tyrosine kinase signaling systems (Andersen et al., 2005) .
Colon carcinoma
Fra-1 overexpression is a common mechanism of constitutive AP-1 activation in tumors (Milde-Langosch, 2005) . Colon carcinoma-derived BE cells overexpress Fra1 in an ERK-dependent manner and suppression of Fra-1 expression with siRNA inhibits cell polarization, motility and invasiveness, by using a mechanism that involves regulation of Rho A and b1 integrin (Vial et al., 2003) .
Breast carcinoma
Metastatic, estrogen receptor negative breast carcinomas have higher levels AP-1 DNA binding activity than less metastatic estrogen receptor positive carcinomas and expression of Fra-1 correlates with AP-1 activity and invasiveness in these cell lines (Philips et al., 1998; Zajchowski et al., 2001) . Overexpression of the Fos family proteins c-Fos, FosB, and Fra-1 significantly increased invasiveness of the ER ( þ ) MCF-7 breast carcinoma cells. Conversely in the aggressive, ER(À) carcinoma cell line MDA-MB-231, suppression of Fra-1 inhibits invasion (Belguise et al., 2005) .
Fibrosarcoma
The HT-1080 fibrosarcoma is an aggressive, metastatic cell line that expresses mutant active N-Ras that is responsible for elevated AP-1 activity (Brown et al., 1984) . Expression of the dominant-negative Fos construct, A-fos, inhibits motility in these cells, coincident with repression of motility effector genes such as the matrix metalloproteinase MMP9, the gelsolin-like actin capping protein, CapG and the p41B subunit of the actin-nucleating complex, Arp2/3 (Sun et al., 1995; Bahassi el et al., 2004) . A-fos expression in these cells induces IGSF4/TSLC1 (Bahassi el et al., 2004), a nectinlike cell adhesion molecule that has tumor suppressor activity (Kuramochi et al., 2001) . Taken together, the inhibition of AP-1 activity, by either dominant-negative or siRNA, demonstrates that AP-1 regulates invasion and motility in human cell lines derived from a wide variety tumor types of diverse origins. These are clinically derived cell lines that are the end product of an intense selective pressure exerted during tumor progression and as such are representative of in vivo tumor cells that are the ultimate targets of antineoplastic therapies. Inhibition of invasion in these cells is a compelling argument that AP-1 activity is a clinically relevant component of cancer pathobiology.
Invasion and other transcription factors
The evidence that AP-1 regulates a program of gene expression that mediates tumor cell invasion is extensive (Tkach et al., 2003) . However, the studies do not address Figure 3 Typical morphological changes that are associated inhibition of AP-1 activity by the dominant-negative protein A-fos. A-fos expressing cells have an increased incidence of actin stress fibers and decreased lamellopodia formation that is associated with reduced motility in vitro. Depicted left to right are breast carcinoma (MDA-MB-231, SKBR3), glioblastoma (U87) and non-small-cell lung carcinoma (A549) cells expressing either a control (top) or A-fos (bottom). Actin cytoskeleton stained with phalloidin (red) and the nucleus is stained with DAPI (blue).
AP-1: a critical transcriptional regulator of invasion BW Ozanne et al the question: how does AP-1 regulate such diverse sets of genes in so many distinct biological contexts? It is perhaps relevant to note that where the dominantnegative molecule A-fos inhibits motility in HT-1080 cells, equivalent levels of the c-Jun dominant-negative mutant, TAM-67 fail to do so (Bahassi el et al., 2004) . These molecules inhibit endogenous AP-1 activity via different mechanisms. TAM-67 competitively inhibits endogenous AP-1 transactivation domains, whereas Afos dominantly inhibits endogenous AP-1 DNA binding activity (Alani et al., 1991; Olive et al., 1997) . The differential behaviour of these mutants in HT-1080 cells allows speculation that AP-1 DNA binding is necessary to regulate invasion effector genes, but that AP-1 transactivation activity is dispensable. It is possible that the transactivation activity is supplied by other transcription factors that cooperate with AP-1 to regulate gene expression. AP-1 dimers can synergize with a variety of other transcription factors (Nolan, 1994; Wisdom, 1999) . This can be achieved by direct physical interaction of these transcription factors with c-Jun via a small region upstream of the DNA binding domain (Bassunk and Leiden, 1995) . This interaction has been demonstrated for the glucocorticoid receptor, estrogen receptor, Ets family proteins, the SMAD family and the Rel family members NF-kB and NF-AT, among others (Diamond et al., 1990; Gaub et al., 1990; Stein et al., 1993; Bassunk and Leiden, 1995; Zhang et al., 1998) . The many permutations of hetero-and homodimer formation among Fos and Jun family members, plus the known interactions of AP-1 with other transcription factor families, offers a mechanism by which the AP-1 transcription factor family can exert a finely tuned regulation of large sets of genes in response to a wide variety of extracellular stimuli and cellular contexts.
Ets
Like AP-1, members of the Ets family are oncogenic transcription factors that are activated by upstream signal transduction cascades and are upregulated in a variety of oncogene transformed cells and human tumors (Seth et al., 2001) . Ectopic expression of PEA3/E1AF confers an invasive phenotype on human cancer cells and invasion correlates with the induction of MMP genes and uPA (Ky et al., 1996) . These and other studies indicate that like AP-1, Ets transcription factors alone are sufficient to induce invasiveness. Antisense and dominant-negative studies suggest that, like AP-1, Ets may also be necessary to induce invasion in clinically derived malignant human tumor cells. Antisense oligonucleotides to Ets-1 reduced invasion in oral cancers. In the same system, HGF induced invasion was partially dependent upon PEA3/E1AF mediated induction of MMP9 (Hanzawa et al., 2000) . Dominant-negative constructs consisting of the Ets domain of Ets-2 inhibit anchorage independent growth and invasion of BT20 breast carcinoma cells (Sapi et al., 1998) and PPC-1 prostate carcinoma cells (Foos and Hauser, 2000) . These studies confirm that expression of Ets family members, particularly, Ets-1, Ets-2 and PEA3/E1AF, is necessary and sufficient for invasiveness in metastatic human tumor cells.
NF-kB
The NF-kB transcription factor is also activated by upstream signal transduction networks and has transforming activity when expressed as the v-rel oncogene.
In fact v-Rel transformation is dependent upon AP-1 activity (Kralova et al., 1998) . NF-kB activity is elevated in breast carcinoma cell lines (Sovak et al., 1997) and has been shown to mediate cell migration and metastasis via overexpression of the chemokine receptor CXCR4 (Helbig et al., 2003) . NF-kB activity is also high in metastatic PC-3 prostate carcinoma cells (Lindholm et al., 2000) and suppression of NF-kB activity by the inhibitor molecule IkB decreases invasion in vitro and expression of MMP9 (Andela et al., 2003) . The MMP9 promoter is coordinately regulated by both AP-1 and NF-kB activity , highlighting the critical nature of this interaction for transformation. Dominantnegative Jun inhibits both AP-1 and NF-kB activity in HPV immortalized human keratinocytes (Li et al., 1998) . As with Ets and AP-1, NF-kB regulates the expression of matrix metalloproteinases and uPA, consistent with a role for this protein in regulating invasion.
TCF/LEF
The b-catenin T-cell factor (TCF)/lymphoid enhancer factor (LEF) transcription factors are responsive to the Wnt signal transduction system and are activated in colon carcinomas harboring mutations in APC. TCF/ LEF and nuclear b-catenin expression correlate with invasiveness in colon carcinoma and over-expression induces invasion in model cell lines (Nguyen et al., 2005) . Like both Ets-1 and NF-kB, TCF/LEF has been shown to synergistically regulate MMP genes with AP-1 via direct interaction with c-Jun (Rivat et al., 2003) . The ability of members of the Ets, NF-kB and TCF/ LEF families to regulate tumor cell invasion correlates with both their responsiveness to upstream oncogenes and their ability to interact with the AP-1 complex and targeting of the same sets of invasion effector. However, the requirement of functional AP-1 DNA binding activity, as indicated by the A-fos mediated inhibition, indicates that the function of these other transcription factors may be dependent upon the AP-1 factor binding to DNA, highlighting a dominant role that AP-1 may play in regulating an extensive, complex program of gene expression that controls the ability of tumor cells to invade and ultimately to develop into life-threatening metastases.
Summary

Main conclusions
Metastasis is the major cause of mortality in cancer patients and tumor cell invasion is critical for metastastic dissemination. Invasiveness is conferred by the constitutive activation of oncogene-mediated signal transduction pathways, particularly the Ras-MAP kinase system that ultimately results in changes in gene expression that mediate invasion. The AP-1 transcription factor is necessary for upstream oncogene function, suggesting that AP-1 is responsible for oncogenemediated invasion. Extensive data in both rat and human fibroblast systems demonstrates that AP-1 regulates direct effectors of invasion such as MMP9, CD44, Ezrin and Krp1. AP-1 also suppresses inhibitors of invasion such as TSC-36, fibronectin, STAT6 and PCDHGC3. These data suggest that AP-1 coordinates a complex program of gene expression that constitutes the invasive phenotype. Inhibition of endogenous AP-1 activity in a variety of human tumor cell lines demonstrates that AP-1 regulation of invasion is widespread in tumor cell biology. Interactions between AP-1 and other transcription factors, and the possible dominant nature of this interaction, hints at the complexity by which this regulation is achieved.
Significance and impact
Tumor cell invasion is a defining charateristic of metastatic diseases and essential to neoplastic dissemination. As such, the invasive phenotype represents a prime target for therapies that are selectively toxic for tumor cells. This puts a premium on understanding the mechanisms by which tumor cells invade. Invasion requires the coordinated expression of a large number of gene products and AP-1's role as a master regulator of gene expression in response to oncogenic signal transduction cascades in a wide variety of tumor cell types underscores its significance in cancer biology. AP-1 regulated effector genes may potentially serve as targets for the development of anti-invasive therapies or pathological markers for advanced, disseminated cancer. Also, these studies demonstrate that the elaboration of the invasive phenotype requires the repression of inhibitors that may serve as the basis of future antimetastatic therapies.
Future directions
The critical role that AP-1 plays in regulating tumor cell invasion is only just emerging. Microarray techniques and proteomic studies on a wide variety of human and murine tumor model systems will reveal the full extent of the genetic program controlled by AP-1. The fact that AP-1 functions cooperatively with other DNA binding transcription factors such as NF-kB and Ets hints at a mechanism by which coordinate expression of functionally related sets of genes is achieved. Bioinfomatic studies on the promoters of coordinately regulated genes may identify characteristic combinations of cis-acting elements that will shed light on the complexity of this control. Further studies that better define the mechanisms that underlie this cooperation may lead to the development of agents that specifically inhibit the synergy between AP-1 and other transcription factors, allowing the regulation of a subset of AP-1 activity that controls the expression of invasion effector genes. The critical function of AP-1 to coordinate a program of gene expression that controls tumor cell invasion may well determine the extent of metastatic dissemination of a malignant tumor and as such becomes a matter of life and death for cancer patients.
